Ninety-Day Risk-Standardized Home Time as a Performance Metric for Cardiac Surgery Hospitals in the United States

Author:

Mentias Amgad1ORCID,Desai Milind Y.1ORCID,Keshvani Neil2ORCID,Gillinov A. Marc1,Johnston Douglas1,Kumbhani Dharam J.2ORCID,Hirji Sameer A.3,Sarrazin Mary-Vaughan45ORCID,Saad Marwan6ORCID,Peterson Eric D.2ORCID,Mack Michael J.7ORCID,Cram Peter8ORCID,Girotra Saket45ORCID,Kapadia Samir1ORCID,Svensson Lars1ORCID,Pandey Ambarish2ORCID

Affiliation:

1. Heart, Vascular and Thoracic Institute, Cleveland Clinic Foundation, OH (A.M., M.Y.D., A.M.G., D.J., S.K., L.S.).

2. Division of Cardiology, Department of Internal Medicine, University of Texas Southwestern Medical Center, Dallas (N.K., D.J.K., E.D.P., A.P.).

3. Division of Cardiac Surgery, Brigham and Women’s Hospital, Harvard Medical School, Boston, MA (S.A.H.).

4. Center for Access and Delivery Research and Evaluation, Iowa City Veterans Affairs Medical Center (M.-V.S., S.G.).

5. Department of Internal Medicine, Carver College of Medicine, University of Iowa, Iowa City (M.-V.S., S.G.).

6. Department of Medicine‚ Division of Cardiology, Alpert Medical School of Brown University, Lifespan Cardiovascular Institute, Providence, RI (M.S.).

7. Division of Cardiology, Baylor Scott and White Health, Plano, TX (M.J.M).

8. Department of Internal Medicine University of Texas Medical Branch, Galveston (P.C.).

Abstract

Background: Assessing hospital performance for cardiac surgery necessitates consistent and valid care quality metrics. The association of hospital-level risk-standardized home time for cardiac surgeries with other performance metrics such as mortality rate, readmission rate, and annual surgical volume has not been evaluated previously. Methods: The study included Medicare beneficiaries who underwent isolated or concomitant coronary artery bypass graft, aortic valve, or mitral valve surgery from January 1, 2013, to October 1, 2019. Hospital-level performance metrics of annual surgical volume, 90-day risk-standardized mortality rate, 90-day risk-standardized readmission rate, and 90-day risk-standardized home time were estimated starting from the day of surgery using generalized linear mixed models with a random intercept for the hospital. Correlations between the performance metrics were assessed using the Pearson correlation coefficient. Patient-level clinical outcomes were also compared across hospital quartiles by 90-day risk-standardized home time. Last, the temporal stability of performance metrics for each hospital during the study years was also assessed. Results: Overall, 919 698 patients (age 74.2±5.8 years, 32% women) were included from 1179 hospitals. Median 90-day risk-standardized home time was 71.2 days (25th–75th percentile, 66.5–75.6), 90-day risk-standardized readmission rate was 26.0% (19.5%–35.7%), and 90-day risk-standardized mortality rate was 6.0% (4.0%–8.8%). Across 90-day home time quartiles, a graded decline was observed in the rates of in-hospital, 90-day, and 1-year mortality, and 90-day and 1-year readmission. Ninety-day home time had a significant positive correlation with annual surgical volume ( r =0.31; P <0.001) and inverse correlation with 90-day risk-standardized readmission rate ( r =–0.40; P  <0.001) and 90-day risk-standardized mortality rate ( r =–0.60; P  <0.001). Use of 90-day home time as a performance metric resulted in a meaningful reclassification in performance ranking of 22.8% hospitals compared with annual surgical volume, 11.6% compared with 90-day risk-standardized mortality rate, and 19.9% compared with 90-day risk-standardized readmission rate. Across the 7 years of the study period, 90-day home time demonstrated the most temporal stability of the hospital performance metrics. Conclusions: Ninety-day risk-standardized home time is a feasible, comprehensive, patient-centered metric to assess hospital-level performance in cardiac surgery with greater temporal stability than mortality and readmission measures.

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Physiology (medical),Cardiology and Cardiovascular Medicine

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3